PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription.

Muscle-invasive bladder cancer is associated with a high frequency of metastasis, and bone is the most common metastatic site outside the pelvis. To clarify its organ-specific characteristics, we generated a successive bone metastatic T24-B bladder cancer subline following tail vein injection of metastatic T24-L cells. Compared with parental T24-L cells, epithelial-like T24-B cells displayed increased adhesion but decreased migration or invasion abilities as well as up-regulation of cytokeratins and down-regulation of vimentin, N-cadherin and MMP2. Mechanically, phosphatidylinositol 3-kinase (PI3K)/Akt targets glycogen synthase kinase-3β (GSK3β)/β-catenin to control ZEB1 gene transcription, and then subsequently regulates the expression of cytokeratins, vimentin and MMP2. Importantly, ZEB1 is essential for bladder cancer invasion in vitro and distant metastasis in vivo, and ZEB1 overexpression was highly correlated with the expression of those downstream markers in clinical tumor samples. Overall, this study reveals a novel mechanism facilitating metastatic bladder cancer cell re-colonization into bone, and confirms the significance of mesenchymal-to-epithelial transition (MET) in formation of bone metastasis.

[1]  Torben F. Ørntoft,et al.  Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer , 2007, Clinical Cancer Research.

[2]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[3]  Í. Lopes-Cendes,et al.  Experimental animal model and RNA interference: a promising association for bladder cancer research , 2009, World Journal of Urology.

[4]  In-Sun Chu,et al.  Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Yibin Kang,et al.  Unravelling the complexity of metastasis — molecular understanding and targeted therapies , 2011, Nature Reviews Cancer.

[6]  Franziska Michor,et al.  Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer , 2012, Clinical Cancer Research.

[7]  Xin-yang Wang,et al.  Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression , 2009, Acta Pharmacologica Sinica.

[8]  D. McCulloch,et al.  Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder , 2005, Clinical & Experimental Metastasis.

[9]  H. von der Maase,et al.  Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma. , 1996, The Journal of urology.

[10]  Xin-yang Wang,et al.  Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development. , 2013, Urologic oncology.

[11]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[12]  Eun-Jung Kim,et al.  Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer , 2010, Molecular Cancer.

[13]  A. Sagalowsky,et al.  Upregulation of TRAG3 gene in urothelial carcinoma of the bladder , 2011, International journal of cancer.

[14]  T. Franke,et al.  PI3K/Akt: getting it right matters , 2008, Oncogene.

[15]  A. Postigo,et al.  β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness , 2011, Proceedings of the National Academy of Sciences.

[16]  Marina Kriajevska,et al.  SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer , 2009, Proceedings of the National Academy of Sciences.

[17]  C. Dinney,et al.  Bladder cancer angiogenesis and metastasis—translation from murine model to clinical trial , 2007, Cancer and Metastasis Reviews.

[18]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[19]  Gerhard Jakse,et al.  The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. , 2009, European urology.

[20]  R. Vessella,et al.  DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis , 2009, Proceedings of the National Academy of Sciences.

[21]  Xin-yang Wang,et al.  Roles of HIF-1α in a novel optical orthotopic spontaneous metastatic bladder cancer animal model. , 2012, Urologic oncology.

[22]  Sridhar Ramaswamy,et al.  A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression. , 2009, Genes & development.

[23]  Mogens Kruhøffer,et al.  Gene Expression in the Urinary Bladder , 2004, Cancer Research.

[24]  H. Moch,et al.  Patterns of Metastasis in Muscle-Invasive Bladder Cancer (pT2–4): An Autopsy Study on 367 Patients , 1999, Urologia Internationalis.

[25]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[26]  E. Thompson,et al.  Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. , 2006, Cancer research.

[27]  J. Clements,et al.  Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.

[28]  Joel P. Christensen,et al.  Homeric Space , 2012, The Classical Review.

[29]  M. Loda,et al.  Novel ZEB1 expression in bladder tumorigenesis , 2011, BJU international.

[30]  Wareef Kabbani,et al.  Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis , 2010, Proceedings of the National Academy of Sciences.

[31]  Jae K. Lee,et al.  A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery , 2007, Proceedings of the National Academy of Sciences.

[32]  H. Frierson,et al.  Profiling the Evolution of Human Metastatic Bladder Cancer , 2004, Cancer Research.

[33]  C. Bucana,et al.  Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. , 1995, The Journal of urology.

[34]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[35]  Xin-yang Wang,et al.  Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors. , 2010, Oncology reports.

[36]  M. Hung,et al.  β-catenin interacts with and inhibits NF-κB in human colon and breast cancer , 2002 .

[37]  J. Richie,et al.  Biology and management of bladder cancer. , 1990, The New England journal of medicine.

[38]  Xin-yang Wang,et al.  Sonic and desert hedgehog signaling in human fetal prostate development , 2007, The Prostate.

[39]  Yung-Hyun Choi,et al.  Gene Signatures for the Prediction of Response to Bacillus Calmette-Guérin Immunotherapy in Primary pT1 Bladder Cancers , 2010, Clinical Cancer Research.

[40]  Guohua Zhang,et al.  Wnt signaling may be activated in a subset of Peutz-Jeghers syndrome polyps closely correlating to LKB1 expression. , 2010, Oncology reports.